https://orcid.org/0000-0003-3423-3745
References
- Barat, C., Simpson, L., and Breslow, E., 2004. Properties of human vasopressin precursor constructs: inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus. Biochemistry ACS biochemistry, 43 (25), 8191–8203.
- Budnik, M., et al., 2020. Serum copeptin and copeptin/NT-proBNP ratio—new tools to differentiate takotsubo syndrome from acute myocardial infarction. Folia medica cracoviensia, 60, 5–14.
- Burgdorf, C., et al., 2012. Release patterns of copeptin and troponin in Tako-Tsubo cardiomyopathy. Peptides elsevier, 34 (2), 389–394.
- Giannitsis, E., et al., 2020. Copeptin combined with either non-high sensitivity or high sensitivity cardiac troponin for instant rule-out of suspected non-ST segment elevation myocardial infarction. Biomarkers taylor biomarkers, 25 (8), 649–610.
- Højagergaard, M.A., et al., 2020. Biomarkers in patients with Takotsubo cardiomyopathy compared to patients with acute anterior ST-elevation myocardial infarction. Biomarkers taylor biomarkers, 25 (2), 137–143.
- Meissner, J., et al., 2011. Endogenous stress response in Tako-Tsubo cardiomyopathy and acute myocardial infarction. European journal of clinical investigation, 41 (9), 964–970.
- Parizadeh, S.M., et al., 2018. The diagnostic and prognostic value of copeptin in cardiovascular disease, current status, and prospective. Journal of cellular biochemistry, 119 (10), 7913–7923.